AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2025
Sep 9, 2025
30786_dirs_2025-09-09_805df765-53c7-4849-9f5f-130f7520ecb8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-RAD LABORATORIES, INC. (BIO BIO.B)
CIK: 0000012208
Period of Report: 2025-09-05
Reporting Person: Allison Schwartz (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-09-06 | Bio-Rad A Common Stock | M | 92 | — | Acquired | 1489 | Direct |
| 2025-09-06 | Bio-Rad A Common Stock | F | 33 | $295.43 | Disposed | 1456 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-09-05 | Restricted Stock Units | $0 | A | 914 | Acquired | Bio-Rad A Common Stock (914) | Direct | |
| 2025-09-06 | Restricted Stock Units | $0 | M | 92 | Disposed | Bio-Rad A Common Stock (92) | Direct |
Footnotes
F1: Shares of Class A common stock acquired on the vesting of restricted stock units.
F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13